|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.54 USD | -0.42% |
|
-3.18% | -27.56% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
| Market Cap | 1.09B 948M 878M 822M 1.54B 103B 1.55B 10.42B 4.04B 50.52B 4.08B 4B 175B | P/E 2026 * |
12.6x | P/E 2027 * | 8.99x |
|---|---|---|---|---|---|
| Enterprise Value | 1.84B 1.6B 1.48B 1.39B 2.61B 173B 2.62B 17.61B 6.83B 85.4B 6.9B 6.75B 297B | EV / Sales 2026 * |
2.1x | EV / Sales 2027 * | 1.6x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | -0.42% | ||
| 1 week | -3.18% | ||
| Current month | -0.21% | ||
| 1 month | -2.56% | ||
| 3 months | -5.36% | ||
| 6 months | -31.38% | ||
| Current year | -27.56% |
| 1 week | 31.69 |  | 34.87 |
| 1 month | 30.13 | | 35.52 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.19 | | 50.79 |
| 3 years | 20.83 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 2024-11-11 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 2021-05-23 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 2022-03-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 2025-05-14 |
John Freund
BRD | Director/Board Member | 72 | 2014-01-31 |
Garen Bohlin
BRD | Director/Board Member | 78 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 05-17 | Sell | Director | -20 | 0.0001% | ||
| 05-14 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -3.18% | +12.44% | +41.88% | 1.09B | |
| -1.21% | -3.04% | +44.03% | +142.51% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.36% | 550B | |
| -2.14% | -4.94% | +16.83% | +58.18% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.78% | 316B | |
| +0.61% | -1.69% | +27.35% | +14.22% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.69% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.41% | 199B | |
| -1.19% | -4.95% | +16.68% | +48.70% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.46% | 154B | |
| Average | -0.31% | -2.95% | +19.34% | +40.54% | 330.34B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.48% | +63.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 875M 763M 706M 661M 1.24B 82.52B 1.25B 8.38B 3.25B 40.62B 3.28B 3.21B 141B | 886M 772M 715M 670M 1.26B 83.59B 1.26B 8.49B 3.29B 41.14B 3.33B 3.25B 143B |
| Net income | 108M 94.36M 87.39M 81.81M 153M 10.21B 154M 1.04B 402M 5.03B 406M 398M 17.45B | 158M 138M 128M 120M 224M 14.94B 226M 1.52B 588M 7.35B 594M 581M 25.53B |
| Net Debt | 751M 655M 606M 568M 1.06B 70.85B 1.07B 7.19B 2.79B 34.87B 2.82B 2.76B 121B | 328M 286M 265M 248M 465M 30.92B 467M 3.14B 1.22B 15.22B 1.23B 1.2B 52.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 33.54 $ | -0.42% | 631,903 |
| 26-06-17 | 33.68 $ | -2.80% | 413,791 |
| 26-06-16 | 34.65 $ | +1.35% | 181,689 |
| 26-06-15 | 34.19 $ | -1.30% | 408,095 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Select your edition
All financial news and data tailored to specific country editions
